Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

254 ARTÍCULOS , VIENDO DEL 61 AL 75

Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study

Morenas-Rodríguez E, Li Y, Nuscher B, Franzmeier N, Xiong C, Suárez-Calvet M, Fagan AM, Schultz S, Gordon BA, Benzinger TLS, Hassenstab J, McDade E, Feederle R, Karch CM, Schlepckow K, Morris JC, Kleinberger G, Nellgard B, Vöglein J, Blennow K, Zetterberg H, Ewers M, Jucker M, Levin J, Bateman RJ, Haass C; Dominantly Inherited Alzheimer Network.

Lancet Neurol. 2022 Apr;21(4):329-341. doi: 10.1016/S1474-4422(22)00027-8.

Biofluid Biomarkers of Alzheimer's Disease: Progress, Problems, and Perspectives

Huang S, Wang YJ, Guo J.

Neurosci Bull. 2022 Jun;38(6):677-691. doi: 10.1007/s12264-022-00836-7. Epub 2022 Mar 19.

Cerebrospinal Fluid Total Tau Protein Correlates With Longitudinal, Progressing Cognitive Dysfunction in Anti-Neural Autoantibody-Associated Dementia and Alzheimer's Dementia: A Case-Control Study

Hansen N, Juhl AL, Grenzer IM, Hirschel S, Teegen B, Fitzner D, Bartels C, Timäus C, Wiltfang J, Malchow B.

Front Immunol. 2022 Mar 3;13:837376. doi: 10.3389/fimmu.2022.837376. eCollection 2022.

Associations between cerebrospinal fluid markers and cognition in ageing and dementia: A systematic review

Saunders TS, Gadd DA, Spires-Jones TL, King D, Ritchie C, Muniz-Terrera G.

Eur J Neurosci. 2022 Nov;56(9):5650-5713. doi: 10.1111/ejn.15656. Epub 2022 May 12.

P-tau217 in Alzheimer's disease

Telser J, Risch L, Saely CH, Grossmann K, Werner P.

Clin Chim Acta. 2022 Jun 1;531:100-111. doi: 10.1016/j.cca.2022.03.018. Epub 2022 Mar 24.

Culture, Ethnicity, and Level of Education in Alzheimer's Disease

Rosselli M, Uribe IV, Ahne E, Shihadeh L.

Neurotherapeutics. 2022 Jan;19(1):26-54. doi: 10.1007/s13311-022-01193-z. Epub 2022 Mar 28.

Early-stage Alzheimer disease: getting trial-ready

Aisen PS, Jimenez-Maggiora GA, Rafii MS, Walter S, Raman R.

Nat Rev Neurol. 2022 Jul;18(7):389-399. doi: 10.1038/s41582-022-00645-6. Epub 2022 Apr 4.

Association of plasma apolipoproteins and levels of inflammation-related factors with different stages of Alzheimer's disease: a cross-sectional study

Wang T, Wang X, Yao Y, Zhao C, Yang C, Han Y, Cai Y.

BMJ Open. 2022 Apr 6;12(4):e054347. doi: 10.1136/bmjopen-2021-054347.

Effects of a staged integral art-based cognitive intervention (SIACI) program in older adults with cognitive impairments: protocol for a randomized controlled trial

Yan YJ, Ma MP, Cai WC, Huang CS, Lin R, Chen YF, Li H.

BMC Geriatr. 2022 Apr 7;22(1):296. doi: 10.1186/s12877-022-02961-4.

Alzheimer's Disease: A Silent Pandemic - A Systematic Review on the Situation and Patent Landscape of the Diagnosis

Goyzueta-Mamani LD, Chávez-Fumagalli MA, Alvarez-Fernandez K, Aguilar-Pineda JA, Nieto-Montesinos R, Davila Del-Carpio G, Vera-Lopez KJ, Lino Cardenas CL.

Recent Pat Biotechnol. 2022;16(4):355-378. doi: 10.2174/1872208316666220408114129.

Spillover: The Approval of New Medications for Alzheimer's Disease Dementia Will Impact Biomarker Disclosure Among Asymptomatic Research Participants

Mozersky J, Roberts JS, Rumbaugh M, Chhatwal J, Wijsman E, Galasko D, Blacker D; AGREED.

J Alzheimers Dis. 2022;90(3):1035-1043. doi: 10.3233/JAD-220113.

Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer's disease

Golriz Khatami S, Salimi Y, Hofmann-Apitius M, Oxtoby NP, Birkenbihl C; Alzheimer’s Disease Neuroimaging Initiative; Japanese Alzheimer’s Disease Neuroimaging Initiative; Alzheimer’s Disease Repository Without Borders Investigators.

Alzheimers Res Ther. 2022 Apr 20;14(1):55. doi: 10.1186/s13195-022-01001-y.

α-synuclein as an emerging pathophysiological biomarker of Alzheimer's disease

Beatino MF, De Luca C, Campese N, Belli E, Piccarducci R, Giampietri L, Martini C, Perugi G, Siciliano G, Ceravolo R, Vergallo A, Hampel H, Baldacci F.

Expert Rev Mol Diagn. 2022 Apr;22(4):411-425. doi: 10.1080/14737159.2022.2068952. Epub 2022 May 6.

Diabetic patients treated with metformin during early stages of Alzheimer's disease show a better integral performance: data from ADNI study

Pomilio C, Pérez NG, Calandri I, Crivelli L, Allegri R; ADNI Alzheimer’s Disease Neuroimaging Initiative; Sevlever G, Saravia F.

Geroscience. 2022 Jun;44(3):1791-1805. doi: 10.1007/s11357-022-00568-6. Epub 2022 Apr 20.

Advances in the development of new biomarkers for Alzheimer's disease

Klyucherev TO, Olszewski P, Shalimova AA, Chubarev VN, Tarasov VV, Attwood MM, Syvänen S, Schiöth HB.

Transl Neurodegener. 2022 Apr 21;11(1):25. doi: 10.1186/s40035-022-00296-z.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias